Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Menactra vs Menomune in Adults 56+
NCT00874549Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2007
- Primary completion
- Jan 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of meningococcal A conjugate vaccine in meningococcal infection (4 arms), sponsored by Sanofi. Primary endpoints: Number of Participants With At Least One Solicited Injection Site Reaction and Number of Participants With At Least One Solicited Systemic Reaction. Started Oct 2007; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT00874549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00874549.